Apollo Endosurgery, Inc. (APEN) |
| 10 0 (0%) 04-03 16:00 |
| Open: | 9.93 |
| High: | 10 |
| Low: | 9.92 |
| Volume: | 1,639,528 |
| Market Cap: | 580(M) |
| PE Ratio: | -9.43 |
| Exchange: | NASDAQ Global Market |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 329.67 |
| Resistance 1: | 325.15 |
| Pivot price: | 323.05 |
| Support 1: | 317.83 |
| Support 2: | 264.43 |
| 52w High: | 10.3 |
| 52w Low: | 3.49 |
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. Additionally, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.
| EPS | 4.330 |
| Book Value | 36.390 |
| PEG Ratio | 0.74 |
| Gross Profit | 24.916 |
| Profit Margin (%) | 11.76 |
| Operating Margin (%) | 10.20 |
| Return on Assets (ttm) | 6.7 |
| Return on Equity (ttm) | 12.7 |
Fri, 20 Feb 2026
Weight Loss and Diet Management Analysis Report 2026-2035: A $45+ Billion Market by 2030 with Weight Watchers, Nutrisystem, Kellogg, Herbalife, Apollo Endosurgery, and Medifast Leading - Yahoo Finance
Wed, 07 Jan 2026
Med tech company begins renovations for new South Congress offices - Austin American-Statesman
Fri, 25 Apr 2025
Apollo Endosurgery, Inc. Reports 28% Revenue Growth in Third Quarter Conference Call and Webcast to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET - ACCESS Newswire
Wed, 26 Apr 2023
Four things to know about our acquisition of Apollo Endosurgery - www.bostonscientific.com
Tue, 04 Apr 2023
Boston Scientific completes $615M acquisition of Austin-based Apollo Endosurgery - Worcester Business Journal
Tue, 04 Apr 2023
Boston Scientific completes Apollo Endosurgery acquisition - MassDevice
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |